PHINIA Q2 2026: Sales Climb 5.6%, Adjusted EBITDA Reaches $130M, Guidance Tightened
PHIN sits 64% above its 52-week low of $48.94.
Summary
PHINIA reported Q2 2026 net sales of $940M (+5.6% YoY) and adjusted EBITDA of $130M. Full-year guidance was refined, and the stoba Group acquisition was announced, expected to close in Q4 2026.
Key Events · Earnings and Guidance · PHIN
-
Q2 Sales Up 5.6%
Net sales reached $940M, driven by volumes in the Americas and the SEM acquisition, partially offset by tariff recoveries.
-
Adjusted EBITDA Rises to $130M
Adjusted EBITDA increased $4M YoY to $130M, with margin of 13.8%, down 40 bps due to higher employee costs and unfavorable mix.
-
Adjusted EPS of $1.53
Adjusted net earnings per diluted share were $1.53, excluding $0.48 in non-operating items, reflecting operational improvements and a lower share count.
-
2026 Guidance Refined
Full-year net sales expected at $3.57B-$3.67B, adjusted EBITDA $485M-$515M, and adjusted free cash flow $210M-$250M.
Analysis · PHIN · Manufacturing
A solid quarter for PHINIA featured sales growth in both segments and higher adjusted EBITDA, even as net earnings edged lower. The company also unveiled the acquisition of stoba Group, a move that bolsters manufacturing capabilities and supply chain resilience. Full-year guidance was refined, with adjusted EBITDA now projected at $485M–$515M and adjusted free cash flow at $210M–$250M. These results and the updated outlook underscore the company's ability to generate cash and return capital to shareholders—$42M in buybacks and $11M in dividends were deployed this quarter.
At the time of this filing, PHIN was trading at $80.30 on NYSE in the Manufacturing sector, with a market capitalization of approximately $3B. The 52-week trading range was $48.94 to $86.94. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.